FDA Inspection 1129205 — Leading Pharma, LLC
The FDA completed an inspection of Leading Pharma, LLC on August 11, 2020 in Fairfield, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 11, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Fairfield, NJ (United States)
Additional Details
Postmarket Adverse Drug Experience (PADE)